SEC 13F Intelligence

Boxer Capital, LLC / ANAB

Boxer Capital, LLC’s Anaptysbio Inc Position

Does Boxer Capital, LLC own Anaptysbio Inc (ANAB)? Not currently — the last reported position was 1.30M shares worth $44M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$44M
Q3 2024
Shares
1.30M
% of Portfolio
+2.14%
Quarters Held
20
position exited

Position History ANAB

Reported value by quarter
Q4 ’19: $21MQ4 ’19Q1 ’20: $18MQ2 ’20: $29MQ3 ’20: $19MQ3 ’20Q4 ’20: $28MQ1 ’21: $28MQ2 ’21: $34MQ2 ’21Q3 ’21: $35MQ4 ’21: $45MQ1 ’22: $32MQ1 ’22Q2 ’22: $26MQ3 ’22: $33MQ4 ’22: $40MQ4 ’22Q1 ’23: $28,288Q2 ’23: $26,442Q3 ’23: $23MQ3 ’23Q4 ’23: $28MQ1 ’24: $29MQ2 ’24: $33MQ2 ’24Q3 ’24: $44Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20241.30M$44M+2.14%
Q2 20241.30M$33M+1.72%
Q1 20241.30M$29M+1.45%
Q4 20231.30M$28M+1.39%
Q3 20231.30M$23M+1.24%
Q2 20231.30M$26,442+1.23%
Q1 20231.30M$28,288+1.39%
Q4 20221.30M$40M+2.12%
Q3 20221.30M$33M+1.87%
Q2 20221.30M$26M+1.67%
Q1 20221.30M$32M+1.65%
Q4 20211.30M$45M+1.75%
Q3 20211.30M$35M+1.23%
Q2 20211.30M$34M+1.19%
Q1 20211.30M$28M+0.95%
Q4 20201.30M$28M+0.90%
Q3 20201.30M$19M+0.66%
Q2 20201.30M$29M+1.28%
Q1 20201.30M$18M+1.25%
Q4 20191.30M$21M+1.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of ANAB.